Neuroleptic drug induced hyperprolactinaemia: Pathophysiology, safety and acceptability

Mancini, 2008, Hyperprolactinemia and prolactinomas, Endocrinology & Metabolism Clinics of North America, 37, 67, 10.1016/j.ecl.2007.10.013 Hellewell, 1998, Antipsychotic tolerability: the attitudes and perceptions of medical professionals, patients and caregivers towards side-effects of antipsychotic therapy, Eur Neuropsychopharmacol, 8, S248 Melmed, 2003, Anterior pituitary, 177 Rung, 2011, Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats, Naunyn Schmiedebergs Arch Pharmacol, 384, 39, 10.1007/s00210-011-0641-y Matos, 2011, Macroprolactinemia – laboratory determination and its clinical significance, Acta Med Port, 24, 929 Kato, 1984, Role of vasoactive intestinal polypeptide (VIP) in regulating the pituitary function in man, Peptides, 5, 389, 10.1016/0196-9781(84)90240-7 Hinuma, 1998, A prolactin-releasing peptide in the brain, Nature, 393, 272, 10.1038/30515 Colao, 2006, Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women, Nat Clin Pract Endocrinol Metab, 2, 200, 10.1038/ncpendmet0160 Campino, 1994, Prolactin bioactivity and the duration of lactational amenorrhea, J Clin Endocrinol Metab, 79, 970 Boyd, 1977, Galactorrhea-amenorrhea syndrome: diagnosis and therapy, Ann Intern Med, 87, 165, 10.7326/0003-4819-87-2-165 Bignami, 2005, The favorable prognostic significance of surgery-induced hyperprolactinemia in nodepositive breast cancer patients: ten-year disease-free survival results, Int J Biol Markers, 20, 60, 10.1177/172460080502000109 Pritchard, 1991, The effect of seizures on hormones, Epilepsia, 32, S46 Kruger, 2002, Orgasm-induced prolactin secretion: feedback control of sexual drive?, Neurosci Biobehav Rev, 26, 31, 10.1016/S0149-7634(01)00036-7 Kruger, 2003, Effects of acute prolactin manipulation on sexual drive and function in males, J. Endocrinol, 179, 357, 10.1677/joe.0.1790357 Walsh, 1997, Hyperprolactinaemia in males: a heterogeneous disorder, Aust N Z J Med, 27, 385, 10.1111/j.1445-5994.1997.tb02196.x Pinzone, 2000, Primary medical therapy of micro- and macroprolactinomas in men, J Clin Endocrinol Metab, 85, 3053 Greenspan, 1989, Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism, Ann Intern Med, 110, 526, 10.7326/0003-4819-110-7-526 Klibanski, 1988, Effects of prolactin and estrogen deficiency in amenorrheic bone loss, J Clin Endocrinol Metab, 67, 124, 10.1210/jcem-67-1-124 Molitch, 2005, Medication-induced hyperprolactinemia, Mayo Clin Proc, 80, 1050, 10.4065/80.8.1050 Haddad, 2004, Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management, Drugs, 64, 2291, 10.2165/00003495-200464200-00003 Hou, 1985, Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis, Am J Kidney Dis, 6, 245, 10.1016/S0272-6386(85)80181-5 Thiel, 1978, Hyperprolactinemia and thyrotropin-releasing factor (TRH) responses in men with alcoholic liver disease, Alcohol Clin Exp Res, 2, 344, 10.1111/j.1530-0277.1978.tb04740.x Honbo, 1978, Serum prolactin levels in untreated primary hypothyroidism, Am J Med, 64, 782, 10.1016/0002-9343(78)90517-X Molitch, 2001, Disorders of prolactin secretion, Endocrinol Metab Clin North Am, 30, 585, 10.1016/S0889-8529(05)70203-6 Stryker, 1985, Reversible hyperthyrotropinemia, hyperthyroxinemia, and hyperprolactinemia due to adrenal insufficiency, Am J Med, 79, 271, 10.1016/0002-9343(85)90022-1 Luciano, 1984, Hyperprolactinemia in polycystic ovary syndrome, Fertil Steril, 41, 719, 10.1016/S0015-0282(16)47838-6 Bracero, 2001, Polycystic ovary syndrome and hyperprolactinemia, Obstet Gynecol Clin North Am, 28, 77, 10.1016/S0889-8545(05)70186-8 Martin, 1985, The natural history of idiopathic hyperprolactinemia, J Clin Endocrinol Metab, 60, 855, 10.1210/jcem-60-5-855 Schlechte, 1989, The natural history of untreated hyperprolactinemia: a prospective analysis, J Clin Endocrinol Metab, 68, 412, 10.1210/jcem-68-2-412 Veldhuis, 1988, Operating characteristics of the hypothalamo-pituitary-gonadal axis in men: circadian, ultradian, and pulsatile release of prolactin and its temporal coupling with luteinizing hormone, J Clin Endocrinol Metab, 67, 116, 10.1210/jcem-67-1-116 Tsigkaropoulou, 2012, Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis, Gend Med, 9, 56, 10.1016/j.genm.2012.01.001 Evans, 1989, Mapping of prolactin and tumor necrosis factor-beta genes on human chromosome 6p using lymphoblastoid cell deletion mutants, Somat Cell Mol Genet, 15, 203, 10.1007/BF01534871 Bole-Feysot, 1998, Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice, Endocrine reviews, 19, 225, 10.1210/edrv.19.3.0334 Kulick, 2005, The relative importance of vasoactive intestinal peptide and peptide histidine isoleucine as physiological regulators of prolactin in the domestic turkey, Gen Comp Endocrinol, 142, 267, 10.1016/j.ygcen.2004.12.024 Ben-Jonathan, 1996, Extrapituitary prolactin: Distribution, regulation, functions, and clinical aspects, Endocrine reviews, 17, 639 Gerlo, 2006, Prolactin in man: A tale of two promoters, BioEssays, 28, 1051, 10.1002/bies.20468 Zinger, 2003, Prolactin expression and secretion by human breast glandular and adipose tissue explants, J Clin Endocrinol Metab, 88, 689, 10.1210/jc.2002-021255 Gregg, 2007, White matter plasticity and enhanced remyelination in the maternal CNS, J Neurosci, 27, 1812, 10.1523/JNEUROSCI.4441-06.2007 Craven, 2006, Prolactin delays hair regrowth in mice, J Endocrinol, 191, 415, 10.1677/joe.1.06685 Sinha YN. Structural variants of prolactin in Pars Distalis of the Pituitary Gland-Structure, Function and Regulation. 1986; 399–412. Sinha, 1995, Structural variants of prolactin: occurrence and physiological significance, Endocr Rev, 16, 354, 10.1210/edrv-16-3-354 Emanuele, 1992, The rat prolactin gene is expressed in brain tissue: detection of normal and alternatively spliced prolactin messenger RNA, Mol Endocrinol, 6, 35 Wilson, 1992, Prolactin message in brain and pituitary of adult male rats is identical: PCR cloning and sequencing of hypothalamic prolactin cDNA from intact and hypophysectomized adult male rats, Endocrinology, 131, 2488, 10.1210/endo.131.5.1339346 Wilson, 1998, Endocrinology Petty, 1999, Prolactin and antipsychotic medications: mechanism of action, Schizophrenia Res, 35, 67, 10.1016/S0920-9964(98)00158-3 Worrel, 2000, Atypical antipsychotic agents: a critical review, Am J Health-syst Pharm, 57, 238, 10.1093/ajhp/57.3.238 Dickson, 2000, Hormonal side effects in women: typical versus atypical antipsychotic treatment, J Clin Psychiatry, 61, 10 Huang, 1993, Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects, Clin Pharmacol Ther, 54, 257, 10.1038/clpt.1993.146 Kleinberg, 1999, Prolactin levels and adverse events in patients treated with risperidone, J Clin Psychopharmacol, 19, 57, 10.1097/00004714-199902000-00011 Crawford, 1997, The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations, Schizophrenia Res, 26, 41, 10.1016/S0920-9964(97)00036-4 Tran, 1997, Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders, J Clin Psychopharmacol, 17, 407, 10.1097/00004714-199710000-00010 Popli, 1998, Risperidone-induced galactorrhea associated with a prolactin elevation, Ann Clin Psychiatry, 10, 31, 10.3109/10401239809148815 Hamner, 1998, Hyperprolactinaemia in antipsychotic-treated patients. Guidelines for avoidance and management, CNS Drugs, 10, 209, 10.2165/00023210-199810030-00005 Medsafe Editorial Team, 1999, Clozapine and hyperglycaemia, Prescriber Update June, 18, 36 Medsafe Editorial Team, 2001, Potentially fatal complications of clozapine therapy: myocarditis, venous thromboembolism and constipation, Prescriber Update February, 20, 14 Inder, 2011, Antipsychotic-Induced Hyperprolactinaemia, Aust N Z J Psychiatry, 45, 830, 10.3109/00048674.2011.589044 Prentice, 1992, Role of neuroleptic drugs and organic mechanisms in the aetiology of menstrual irregularities in schizophrenic women, Schizophrenia Res, 6, 114, 10.1016/0920-9964(92)90144-T Ghadirian, 1982, Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients, J Nerv Men Dis, 170, 463, 10.1097/00005053-198208000-00004 Magharious, 1998, Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia, Psychiatry Res, 77, 159, 10.1016/S0165-1781(97)00137-6 Smith, 2002, The effects of antipsychotic-induced hyperprolactinemia on the hypothalamic-pituitary-gonadal axis, J Cli Psychopharmacol, 22, 109, 10.1097/00004714-200204000-00002 Peuskens, 1995, Risperidone in the treatment of patients with chronic schizophrenia: a multinational, multi-centre, double-blind, parallel-group study versus haloperidol (Risperidone Study Group), Bri J Psychiatry, 166, 712, 10.1192/bjp.166.6.712 Peters, 1986, Inhibition of lactation by a long-acting bromocriptine, Obstet Gynecol, 67, 82 Wesselmann, 1995, Galactorrhea: subjective response by schizophrenic patients, Acta Psychiatrica Scandinavica, 91, 152, 10.1111/j.1600-0447.1995.tb09758.x Ghadirian, 1982, Sexual dysfunction and plasma prolactin levels in neuroleptic-treated schizophrenic outpatients, J Nerv Mental Dis, 170, 463, 10.1097/00005053-198208000-00004 Finn, 1990, Subjective utility ratings of neuroleptics in treating schizophrenia, Psychol Med, 20, 843, 10.1017/S0033291700036539 Barnes, 1993, Psychiatric drugs and sexuality, Sexual Pharmacol, 176 Royal College of Physicians, 1999 Parfitt, 1994, Osteonal and hemi-osteonal remodelling: the spatial and temporal framework for signal traffic in adult human bone, J Cell Biochem, 55, 273, 10.1002/jcb.240550303